Core summary of product characteristics for human plasma-derived hepatitis B immunoglobulin for intravenous use

Current effective version

PDF iconAdopted guideline

Reference numberCPMP/BPWG/4027/02
Published27/04/2006
Effective from01/11/2006
KeywordsHepatitis B immunoglobulin, summary of product characteristics (SPC)
DescriptionThis document describes the information to be included in the summary of product characteristics for human hepatitis B immunoglobulin for intravenous administration.


Related content


How useful was this page?

Add your rating